Our study was able to broaden the understanding of the role of M2-like TAMs in BC biology and prognostic prediction, and DLG3 is expected to be a novel predictive biomarker of BC prognosis and immunotherapeutic response. The gene discussed is DLG3; the disease is breast cancer.